Dr. Reddys Laboratories informs about company updates

01 Feb 2020 Evaluate

Dr. Reddys Laboratories has informed that the Company has filed its unaudited condensed consolidated interim financial statements prepared under IFRS in Form 6-K for the quarter ended December 31, 2019, with the United States Securities and Exchange Commission on January 31, 2020. A copy of the Form 6-K is attached. The Form 6-K is also available on the Company’s website, www.drreddys.com. 

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1275.05 -1.95 (-0.15%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×